Olinvacimab (anti-VEGFR2) 是一种人抗 VEGFR2 单克隆抗体。Olinvacimab (anti-VEGFR2) 抑制 VEGF 与 KDR 结合，Kd 值为 0.23 nM。Olinvacimab (anti-VEGFR2) 具有抗血管生成活性。Olinvacimab (anti-VEGFR2) 可用于复发性胶质母细胞瘤和乳腺癌的研究。
Olinvacimab (anti-VEGFR2) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab (anti-VEGFR2) inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab (anti-VEGFR2) has antiangiogenic activity. Olinvacimab (anti-VEGFR2) can be used for the research of recurrent glioblastoma and breast cancer.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg
Olinvacimab (anti-VEGFR2) (Ab182846) - Flow Cytometry
Flow Cytometry analysis of HUVEC cells labelling VEGFR2 (red) with Olinvacimab (anti-VEGFR2) (Ab182846). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Olinvacimab (anti-VEGFR2) (Ab182846) - SEC
The purity of Olinvacimab (anti-VEGFR2) (Ab182846) is more than 95% verified by HPLC.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
 ZJ24F0404829 |
分析证书 | Ab182846 |
| ZJ24F0404830 |
分析证书 | Ab182846 |
| ZJ24F0404831 |
分析证书 | Ab182846 |
我们的级别选择指南涵盖了目录中所有的变体的纯度、稳定剂状态和应用适用性。
查看 Animal Free 级别指南 → 查看 Carrier Free 级别指南 → 查看 Recombinant 级别指南 → 查看 Validated 级别指南 → 查看 ExactAb™ 级别指南 → 查看 Low Endotoxin 级别指南 → 查看 Azide Free 级别指南 →
危险品化学品经营许可证（带存储）